{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:34:41Z","timestamp":1793032481210,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Young and Middle-Aged Academic Leaders of Health in Henan Province","award":["HNSWJW-2021001"],"award-info":[{"award-number":["HNSWJW-2021001"]}]},{"name":"Youth Science Foundation Project of Henan Province","award":["232300421285"],"award-info":[{"award-number":["232300421285"]}]},{"name":"Joint Project of Medical Science and Technology of Henan Province","award":["LHGJ20220498"],"award-info":[{"award-number":["LHGJ20220498"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02924-4","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T05:02:52Z","timestamp":1729314172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Single-atom nanozyme liposome-integrated microneedles for in situ drug delivery and anti-inflammatory therapy in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peimiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangpeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"2924_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE. Lang, Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"key":"2924_CR2","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.ncl.2016.06.012","volume":"34","author":"A Lee","year":"2016","unstructured":"Lee A, Gilbert RM. Epidemiology of Parkinson Disease. Neurol Clin. 2016;34:955\u201365.","journal-title":"Neurol Clin"},{"key":"2924_CR3","doi-asserted-by":"crossref","unstructured":"Wu J, Cui X, Ke PC, Mortimer M, Wang X, Bao L, et al. Nanomaterials as novel agents for amelioration of Parkinson\u2019s disease. Nano Today. 2021;41:101328.","DOI":"10.1016\/j.nantod.2021.101328"},{"key":"2924_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nrd.2018.184","volume":"17","author":"D Charvin","year":"2018","unstructured":"Charvin D, Medori R, Hauser RA, Rascol O. Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs. Nat Rev Drug Discov. 2018;17:844.","journal-title":"Nat Rev Drug Discov"},{"key":"2924_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS. Emerging therapies in Parkinson disease-repurposed drugs and new approaches. Nat Rev Neurol. 2019;15:204\u201323.","journal-title":"Nat Rev Neurol"},{"key":"2924_CR6","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1038\/s41467-020-16544-7","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T, Xiao B, Xiang F, Tan J, Chen Z, Zhang X, Wu C, Mao Z, Luo G, Chen X, Deng J. Ultrasmall copper\u2013based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat Commun. 2020;11:2788.","journal-title":"Nat Commun"},{"key":"2924_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/jacs.8b11856","volume":"141","author":"C Hao","year":"2019","unstructured":"Hao C, Qu A, Xu L, Sun M, Zhang H, Xu C, Kuang H. Chiral molecule-mediated porous cu (x)O nanoparticle clusters with antioxidation activity for ameliorating Parkinson\u2019s Disease. J Am Chem Soc. 2019;141:1091\u20139.","journal-title":"J Am Chem Soc"},{"key":"2924_CR8","doi-asserted-by":"publisher","first-page":"21702","DOI":"10.1021\/jacs.0c08395","volume":"142","author":"M Ma","year":"2020","unstructured":"Ma M, Liu Z, Gao N, Pi Z, Du X, Ren J, Qu X. Self-protecting Biomimetic Nanozyme for selective and synergistic clearance of Peripheral amyloid-beta in an Alzheimer\u2019s Disease Model. J Am Chem Soc. 2020;142:21702\u201311.","journal-title":"J Am Chem Soc"},{"key":"2924_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1021\/acsami.9b17509","volume":"12","author":"H He","year":"2020","unstructured":"He H, Shi X, Wang J, Wang X, Wang Q, Yu D, Ge B, Zhang X, Huang F. Reactive oxygen species\u2013Induced Aggregation of Nanozymes for Neuron Injury. ACS Appl Mater Interfaces. 2020;12:209\u201316.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2924_CR10","doi-asserted-by":"crossref","unstructured":"Wu C, Han X, Feng W, Liu Z, Chen L, Zhou B, et al. Multi-enzymatic activities of ultrasmall ruthenium oxide for anti-inflammation and neuroprotection. Chem Eng J. 2021;411:128543.","DOI":"10.1016\/j.cej.2021.128543"},{"key":"2924_CR11","doi-asserted-by":"publisher","first-page":"14267","DOI":"10.1002\/anie.201708573","volume":"56","author":"N Singh","year":"2017","unstructured":"Singh N, Savanur MA, Srivastava S, D\u2019Silva P, Mugesh G. A Redox Modulatory Mn3O4 Nanozyme with Multi-enzyme Activity provides efficient cytoprotection to human cells in a Parkinson\u2019s Disease Model. Angew Chem Int Ed Engl. 2017;56:14267\u201371.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2924_CR12","doi-asserted-by":"crossref","unstructured":"Ma X, Hao J, Wu J, Li Y, Cai X, Zheng Y. Prussian Blue Nanozyme as a pyroptosis inhibitor alleviates neurodegeneration. Adv Mater. 2022;34:e2106723.","DOI":"10.1002\/adma.202106723"},{"key":"2924_CR13","doi-asserted-by":"crossref","unstructured":"Li Q, Wu T, Akakuru OU, Song N, Liu W, Jiang W, et al. A dual synergetic nanoreactor for managing parkinson\u2019s disease by regulating inflammation and mitigating oxidative damage. Adv Func Mater. 2023;33:214826.","DOI":"10.1002\/adfm.202214826"},{"key":"2924_CR14","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.7150\/thno.83370","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang L, Wang M, Li P. The applications of nanozymes in neurological diseases: from mechanism to design. Theranostics. 2023;13:2492\u2013514.","journal-title":"Theranostics"},{"key":"2924_CR15","doi-asserted-by":"crossref","unstructured":"Zhang R, Xue B, Tao Y, Zhao H, Zhang Z, Wang X, et al. Edge-Site Engineering of defective Fe-N(4) nanozymes with boosted catalase-like performance for retinal vasculopathies. Adv Mater. 2022;34:e2205324.","DOI":"10.1002\/adma.202205324"},{"key":"2924_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3892\/ol.2016.5383","volume":"13","author":"F Meng","year":"2017","unstructured":"Meng F, Wang J, Ding F, Xie Y, Zhang Y, Zhu J. Neuroprotective effect of matrine on MPTP\u2013induced Parkinson\u2019s disease and on Nrf2 expression. Oncol Lett. 2017;13:296\u2013300.","journal-title":"Oncol Lett"},{"key":"2924_CR17","first-page":"105","volume":"14","author":"G Cheng","year":"2022","unstructured":"Cheng G, Liu Y, Ma R, Cheng G, Guan Y, Chen X, Wu Z, Chen T. Anti-parkinsonian therapy: strategies for crossing the blood-brain barrier and Nano-Biological effects of nanomaterials. Nanomicro Lett. 2022;14:105.","journal-title":"Nanomicro Lett"},{"key":"2924_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","volume":"7","author":"E Nance","year":"2021","unstructured":"Nance E, Pun SH, Saigal R, Sellers DL. Drug delivery to the central nervous system. Nat Reviews Mater. 2021;7:314\u201331.","journal-title":"Nat Reviews Mater"},{"key":"2924_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","volume":"358","author":"J Liao","year":"2023","unstructured":"Liao J, Fan L, Li Y, Xu QQ, Xiong LY, Zhang SS, Liu JH, Xiao ZC, Zhang C, Yang J, Chen ZS, Xiao K, Wang TF, Lu Y. Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies. J Control Release. 2023;358:439\u201364.","journal-title":"J Control Release"},{"key":"2924_CR20","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang W, Zhang D, Sun Y, Li F, Zheng M, et al. Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy. Exploration 2022;2:20210274.","DOI":"10.1002\/EXP.20210274"},{"key":"2924_CR21","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1021\/acsanm.0c01506","volume":"3","author":"CE Boone","year":"2020","unstructured":"Boone CE, Wang C, Lopez-Ramirez MA, Beiss V, Shukla S, Chariou PL, Kupor D, Rueda R, Wang J, Steinmetz NF. Active Microneedle Administration of Plant Virus nanoparticles for Cancer in situ vaccination improves immunotherapeutic efficacy. ACS Appl Nano Mater. 2020;3:8037\u201351.","journal-title":"ACS Appl Nano Mater"},{"key":"2924_CR22","doi-asserted-by":"crossref","unstructured":"Yang J, Yang J, Gong X, Zheng Y, Yi S, Cheng Y, et al. Recent progress in Microneedles-mediated diagnosis, therapy, and Theranostic systems. Adv Healthc Mater. 2022;11:e2102547.","DOI":"10.1002\/adhm.202102547"},{"key":"2924_CR23","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1074\/jbc.M110.186643","volume":"286","author":"LF Dong","year":"2011","unstructured":"Dong LF, Jameson VJ, Tilly D, Cerny J, Mahdavian E, Marin-Hernandez A, Hernandez-Esquivel L, Rodriguez-Enriquez S, Stursa J, Witting PK, Stantic B, Rohlena J, Truksa J, Kluckova K, Dyason JC, Ledvina M, Salvatore BA, Moreno-Sanchez R, Coster MJ, Ralph SJ, Smith RA, Neuzil J. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem. 2011;286:3717\u201328.","journal-title":"J Biol Chem"},{"key":"2924_CR24","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.freeradbiomed.2011.02.032","volume":"50","author":"LF Dong","year":"2011","unstructured":"Dong LF, Jameson VJ, Tilly D, Prochazka L, Rohlena J, Valis K, Truksa J, Zobalova R, Mahdavian E, Kluckova K, Stantic M, Stursa J, Freeman R, Witting PK, Norberg E, Goodwin J, Salvatore BA, Novotna J, Turanek J, Ledvina M, Hozak P, Zhivotovsky B, Coster MJ, Ralph SJ, Smith RA, Neuzil J. Mitochondrial targeting of alpha-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy. Free Radic Biol Med. 2011;50:1546\u201355.","journal-title":"Free Radic Biol Med"},{"key":"2924_CR25","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1074\/jbc.M009093200","volume":"276","author":"GF Kelso","year":"2001","unstructured":"Peng H, Yao F, Zhao J, Zhang W, Chen L, Wang X, et al.\u00a0Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration. 2023;3:20220115.","journal-title":"J Biol Chem"},{"key":"2924_CR26","doi-asserted-by":"crossref","unstructured":"Wang Z, Yang Z, Jiang J, Shi Z, Mao Y, Qin N, et al. Silk microneedle patch capable of On-demand multidrug delivery to the brain for glioblastoma treatment. Adv Mater. 2022;34:e2106606.","DOI":"10.1002\/adma.202106606"},{"key":"2924_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41467-020-14788-x","volume":"11","author":"Y Wei","year":"2020","unstructured":"Wei Y, Lu M, Mei M, Wang H, Han Z, Chen M, Yao H, Song N, Ding X, Ding J, Xiao M, Hu G. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Nat Commun. 2020;11:941.","journal-title":"Nat Commun"},{"key":"2924_CR28","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1021\/acscentsci.2c00741","volume":"8","author":"Y Liu","year":"2022","unstructured":"Liu Y, Luo J, Liu Y, Liu W, Yu G, Huang Y, Yang Y, Chen X, Chen T. Brain-targeted Biomimetic Nanodecoys with Neuroprotective effects for Precise Therapy of Parkinson\u2019s Disease. ACS Cent Sci. 2022;8:1336\u201349.","journal-title":"ACS Cent Sci"},{"key":"2924_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26\u201341.","journal-title":"Nat Rev Cancer"},{"key":"2924_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ana.24220","volume":"76","author":"LL Dugan","year":"2014","unstructured":"Dugan LL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, Loftin S, Flores H, Moerlein SM, Polich J, Tabbal SD, Mink JW, Perlmutter JS. Carboxyfullerene neuroprotection postinjury in parkinsonian nonhuman primates. Ann Neurol. 2014;76:393\u2013402.","journal-title":"Ann Neurol"},{"key":"2924_CR31","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.tibtech.2019.04.006","volume":"37","author":"A Oddo","year":"2019","unstructured":"Oddo A, Peng B, Tong Z, Wei Y, Tong WY, Thissen H. Voelcker, advances in Microfluidic Blood-Brain Barrier (BBB) models. Trends Biotechnol. 2019;37:1295\u2013314.","journal-title":"Trends Biotechnol"},{"key":"2924_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura AN, Paumier A, Onur TS, Allen NJ. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci. 2023;24:23\u201339.","journal-title":"Nat Rev Neurosci"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02924-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02924-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T21:02:34Z","timestamp":1729371754000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02924-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02924-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Institution Animal Ethics Committee of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethlics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"643"}}